Results 191 to 200 of about 68,267 (269)

Factors contributing to the development of hemophilic arthropathy: A real-world study. [PDF]

Ann Hematol
Ardila J, Diaz-Puentes M, Guerrero M, Escobar A, Avila-Rueda J, Jaramillo M, Buitrago D, Restrepo J, Hernández-Castillo C, Prieto-Pinto L.   +9 more
europepmc   +1 more source

Genetics and Ethics: Reaffirming the Tragic Vision [PDF]

, 1973
Smith, Harmon L.
core   +1 more source

Understanding Treatment Care and Delays in Acquired Hemophilia A: A Population-Based Study From Nova Scotia, Canada. [PDF]

EJHaem
Blackman R, Chen LYC, Keating MM, Quinn J, Robinson S.   +4 more
europepmc   +1 more source

Translational insights from nonclinical studies of AAV gene therapies for hemophilia: mechanisms underpinning variability and durability of gene expression. [PDF]

Ther Adv Hematol
Fong S, Swystun LL, Batty P, Lillicrap D.   +3 more
europepmc   +1 more source

Rebalancing Hemostasis: Fitusiran as a First-in-Class RNAi Therapy in Hemophilia A and B. [PDF]

Health Sci Rep
Rehman RU, Fatima R, Akilimali A.
europepmc   +1 more source

QFitlia (Fitusiran): redefining hemophilia treatment with RNAi therapy. A correspondence. [PDF]

Ann Med Surg (Lond)
Lohano G, Lohano G, Lohana RR, Memon S, Lohana S, Yokolo H.   +5 more
europepmc   +1 more source

Enhancing Hemophilia A Care Through Home-Based Prophylaxis: Real-World Outcomes of a National Patient Support Program in Mexico. [PDF]

J Clin Med
Rico-Alba I, Guzmán AR, Marquez-Gonzalez H, Zurita-Cruz JN.   +3 more
europepmc   +1 more source